Home / ALIVUS.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ALIVUS.NS make money? Does ALIVUS.NS have pricing power? What's the Earnings Whisper? Will ALIVUS.NS profit more as the business scales? What is ALIVUS.NS's management track record? Is ALIVUS.NS's current price justified?

Alivus Life Sciences Limited

₹1309.5 +$401.95 (+44.29%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹1341.8

Day Range

₹1306.1₹1340.7

Year Range

₹819₹1493.8

Market Cap

160.77B

AVG Volume

144.87K

Trailing/Forward PE

26.66/20.33

PEG ratio

1.29

Dividend Yield

0.38%

Next Earnings Date

2026-11-05

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

ALIVUS.NS Revenue (INR) by quarter, trailing twelve months
Period	Revenue (INR)
26 Q1	25.9B
25 Q4	25.52B
25 Q3	24.65B
25 Q2	24.34B
25 Q1	23.53B
24 Q4	23.4B

Net Income (INR) · TTM

ALIVUS.NS Net Income (INR) by quarter, trailing twelve months
Period	Net Income (INR)
26 Q1	6.03B
25 Q4	5.64B
25 Q3	5.44B
25 Q2	5.3B
25 Q1	4.96B
24 Q4	4.86B

Operating Income (INR) · TTM

ALIVUS.NS Operating Income (INR) by quarter, trailing twelve months
Period	Operating Income (INR)
26 Q1	7.58B
25 Q4	7.22B
25 Q3	7.12B
25 Q2	6.75B
25 Q1	6.34B
24 Q4	6.24B

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (INR) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Alivus Life Sciences Limited

Video analysis: ALIVUS.NS

News: ALIVUS.NS

Similar companies